(Q44097966)

English

Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules

scientific article published on 7 June 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules (English)

1 reference

Europe PubMed Central

29 November 2017

author name string

Green TA

1

1 reference

Europe PubMed Central

29 November 2017

Gehrke BJ

2

1 reference

Europe PubMed Central

29 November 2017

Bardo MT

3

1 reference

Europe PubMed Central

29 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 June 2002

1 reference

Europe PubMed Central

29 November 2017

Psychopharmacology

1 reference

Europe PubMed Central

29 November 2017

162

1 reference

Europe PubMed Central

29 November 2017

4

1 reference

Europe PubMed Central

29 November 2017

373-378

1 reference

Europe PubMed Central

29 November 2017

https://scigraph.springernature.com/pub.10.1007/s00213-002-1158-3

0 references

Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Acute amino acid loads that deplete brain serotonin fail to alter behavior.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Trial 2 in the elevated plus-maze: a different form of fear?

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Mood state and brain electric activity in ecstasy users.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

5-HT and anxiety

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1158-3

21 January 2018

Identifiers

10.1007/S00213-002-1158-3

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44097966&oldid=2106567753"